Abstract 269
| Group I (n = 111) | Group II (n = 203) | p Value | |
|---|---|---|---|
| Baseline | |||
| Age (years) | 57 (5) | 64 (6) | <0.001 |
| Body mass index (kg/m2) | 31 (4) | 29 (4) | <0.001 |
| Systolic BP (mmHg) | 151 (15) | 166 (16) | 0.648 |
| Diastolic BP (mmHg) | 83 (9) | 90 (10) | 0.002 |
| eGFR (ml/min) | 103 (94–119) | 74 (67–81) | <0.001 |
| Plasma glucose (mmol/l) | 6.9 (2.9) | 6.6 (2.5) | 0.194 |
| Cholesterol (mmol/l) | 5.6 (1.1) | 6.0 (1.1) | 0.719 |
| Triglycerides (mmol/l) | 1.87 (1.35–2.81) | 1.55 (1.16–2.23) | 0.050 |
| HDL cholesterol (mmol/l) | 1.15 (0.26) | 1.41 (0.16) | 0.020 |
| 5-year follow-up | |||
| Systolic BP (mmHg) | 126 (15) | 139 (15) | 0.740 |
| Diastolic BP (mmHg) | 72 (8) | 77 (9) | 0.004 |
| Glucose (mmol/l) | 6.2 (2.5) | 6.3 (1.8) | 0.400 |
| Cholesterol (mmol/l) | 4.41 (1.05) | 1.65 (1.06) | 0.527 |
| Triglycerides (mmol/l) | 1.3 (0.9–2.1) | 1.2 (0.9–1.8) | 0.007 |
| HDL cholesterol (mmol/l) | 1.22 (0.33) | 1.39 (0.40) | 0.020 |
| eGFR (ml/min) | 94 (83–108) | 65 (59–73) | <0.001 |